INS and metabolic disease: Insulin may act on mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK), which mediates signals to mainly regulate cell growth and proliferation; in insulin resistance, these mediators are impaired and may provoke metabolic diseases and CV-associated alterations [160,161].